EphB receptor signaling in mouse spinal cord contributes to physical dependence on morphine

FASEB Journal

Volumn 23, Issue 1, 2009, Pages 90-98

  Liu, Wen Tao ^a   Li, Hao Chuan ^a   Song, Xue Song ^a   Huang, Zhi Jiang ^a   Song, Xue Jun ^a,b  

^a Parker University Research Institute   (United States)

^b XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

c Fos; CREB; ERK; NR2B; Opiate withdrawal

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; EPHRIN RECEPTOR B1; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN C FOS;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; MALE; MORPHINE ADDICTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SPINAL CORD; WITHDRAWAL SYNDROME;

ANIMALS; CALCITONIN GENE-RELATED PEPTIDE; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION; MALE; MICE; MORPHINE; MORPHINE DEPENDENCE; PROTO-ONCOGENE PROTEINS C-FOS; RECEPTORS, EPH FAMILY; RECEPTORS, N-METHYL-D-ASPARTATE; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; SPINAL CORD;

EID: 58249123288     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.08-114462     Document Type: Article

References (65)

1. Bailey, C. P., and Connor, M. (2005) Opioids: cellular mechanisms of tolerance and physical dependence. Curr. Opin. Pharmacol. 5, 60-68
2. Bohn, L. M., Gainetdinov, R. R., Lin, F. T., Lefkowitz, R. J., and Caron, M. G. (2000) Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence. Nature 408, 720-723
3. King, M., Su, W., Chang, A., Zuckerman, A., and Pasternak, G. W. (2001) Transport of opioids from the brain to the periphery by P-glycoprotein: peripheral actions of central drugs. Nat. Neurosci. 4, 268-274
4. Muscoli, C., Cuzzocrea, S., Ndengele, M. M., Mollace, V., Porreca, F., Fabrizi, F., Esposito, E., Masini, E., Matuschak, G. M., and Salvemini, D. (2007) Therapeutic manipulation of peroxynitrite attenuates the development of opiate-induced antinociceptive tolerance in mice. J. Clin. Invest. 117, 3530-3539
5. Pasternak, G. W. (2007) When it comes to opiates, just say NO. J. Clin. Invest. 117, 3185-3187
6. Zachariou, V., Georgescu, D., Sanchez, N., Rahman, Z., DiLeone, R., Berton, O., Neve, R. L., Sim-Selley, L. J., Selley, D. E., Gold, S. J., and Nestler, E. J. (2003) Essential role for RGS9 in opiate action. Proc. Natl. Acad. Sci. U. S. A. 100, 13656-13661
7. Inoue, M., Mishina, M., and Ueda, H. (2003) Locus-specific rescue of GluRepsilon1 NMDA receptors in mutant mice identifies the brain regions important for morphine tolerance and dependence. J. Neurosci. 23, 6529-6536
8. Inturrisi, C. E. (2002) Clinical pharmacology of opioids for pain. Clin. J. Pain. 18, S3-S13
9. Kolesnikov, Y. A., Pick, C. G., Ciszewska, G., and Pasternak, G. W. (1993) Blockade of tolerance to morphine but not to kappa opioids by a nitric oxide synthase inhibitor. Proc. Natl. Acad. Sci. U. S. A. 90, 5162-5166
10. Pasternak, G. W., and Kolesnikov, Y. (2005) The NMDA/nitric oxide synthase cascade in opioid analgesia and tolerance. In Contemporary Clinical Neuroscience: Glutamate and Addiction (Herman, B. H., ed) pp. 409-416, Humana Press, Totowa, NJ, USA
11. Trujillo, K. A., and Akil, H. (1991) Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science 251, 85-87
12. Barrot, M., Olivier, J. D., Perrotti, L. I., DiLeone, R. J., Berton, O., Eisch, A. J., Impey, S., Storm, D. R., Neve, R. L., Yin, J. C., Zachariou, V., and Nestler, E. J. (2002) CREB activity in the nucleus accumbens shell controls gating of behavioral responses to emotional stimuli. Proc. Natl. Acad. Sci. U. S. A. 99, 11435-11440
13. Nestler, E. J. (2001) Molecular basis of long-term plasticity underlying addiction. Nat. Rev. Neurosci. 2, 119-128
14. Shaw-Lutchman, T. Z., Barrot, M., Wallace, T., Gilden, L., Zachariou, V., Impey, S., Duman, R. S., Storm, D., and Nestler, E. J. (2002) Regional and cellular mapping of cAMP response element-mediated transcription during naltrexone-precipitated morphine withdrawal. J. Neurosci. 22, 3663-3672
15. Sweatt, J. D. (2004) Mitogen-activated protein kinases in synaptic plasticity and memory. Curr. Opin. Neurobiol. 14, 311-317
16. Chen, Z. L., Yu, W. M., and Strickland, S. (2007) Peripheral regeneration. Annu. Rev. Neurosci. 30, 209-233
17. Krull, C. E., Lansford, R., Gale, N. W., Collazo, A., Marcelle, C., Yancopoulos, G. D., Fraser, S. E., and Bronner-Fraser, M. (1997) Interactions of Eph-related receptors and ligands confer rostrocaudal pattern to trunk neural crest migration. Curr. Biol. 7, 571-580
18. Wang, H. U., and Anderson, D. J. (1997) Eph family transmembrane ligands can mediate repulsive guidance of trunk neural crest migration and motor axon outgrowth. Neuron. 18, 383-396
19. Wilkinson, D. G. (2000) Eph receptors and ephrins: regulators of guidance and assembly. Int. Rev. Cytol. 196, 177-244
20. Wilkinson, D. G. (2001) Multiple roles of EPH receptors and ephrins in neural development. Nat. Rev. Neurosci. 2, 155-164
21. Dalva, M. B., Takasu, M. A., Lin, M. Z., Shamah, S. M., Hu, L., Gale, N. W., and Greenberg, M. E. (2000) EphB receptors interact with NMDA receptors and regulate excitatory synapse formation. Cell 103, 945-956
22. Grunwald, I. C., Korte, M., Adelmann, G., Plueck, A., Kullander, K., Adams, R. H., Frotscher, M., Bonhoeffer, T., and Klein, R. (2004) Hippocampal plasticity requires postsynaptic ephrinBs. Nat. Neurosci. 7, 33-40
23. Grunwald, I. C., Korte, M., Wolfer, D., Wilkinson, G. A., Unsicker, K., Lipp, H. P., Bonhoeffer, T., and Klein, R. (2001) Kinase-independent requirement of EphB2 receptors in hippocampal synaptic plasticity. Neuron 32, 1027-1040
24. Henderson, J. T., Georgiou, J., Jia, Z., Robertson, J., Elowe, S., Roder, J. C., and Pawson, T. (2001) The receptor tyrosine kinase EphB2 regulates NMDA-dependent synaptic function. Neuron 32, 1041-1056
25. Takasu, M. A., Dalva, M. B., Zigmond, R. E., and Greenberg, M. E. (2002) Modulation of NMDA receptor-dependent calcium influx and gene expression through EphB receptors. Science 295, 491-495
26. Mao, J. (1999) NMDA and opioid receptors: their interactions in antinociception, tolerance and neuroplasticity. Brain Res. Brain Res. Rev. 30, 289-304
27. Mao, J., Sung, B., Ji, R. R., and Lim, G. (2002) Chronic morphine induces downregulation of spinal glutamate transporters: implications in morphine tolerance and abnormal pain sensitivity. J. Neurosci. 22, 8312-8323
28. Mayer, D. J., Mao, J., Holt, J., and Price, D. D. (1999) Cellular mechanisms of neuropathic pain, morphine tolerance, and their interactions. Proc. Natl. Acad. Sci. U. S. A. 96, 7731-7736
29. Noda, Y., and Nabeshima, T. (2004) Opiate physical dependence and N-methyl-D-aspartate receptors. Eur. J. Pharmacol. 500, 121-128
30. Zhu, H., and Barr, G. A. (2001) Inhibition of morphine withdrawal by the NMDA receptor antagonist MK-801 in rat is age-dependent. Synapse 40, 282-293
31. Hamdy, M. M., Noda, Y., Miyazaki, M., Mamiya, T., Nozaki, A., Nitta, A., Sayed, M., Assi, A. A., Gomaa, A., and Nabeshima, T. (2004) Molecular mechanisms in dizocilpine-induced attenuation of development of morphine dependence: an association with cortical Ca2+/calmodulin-dependent signal cascade. Behav. Brain Res. 152, 263-270
32. Liang, D., Li, X., and Clark, J. D. (2004) Increased expression of Ca2+/calmodulin-dependent protein kinase II alpha during chronic morphine exposure. Neuroscience 123, 769-775
33. Lu, L., Zeng, S., Liu, D., and Ceng, X. (2000) Inhibition of the amygdala and hippocampal calcium/calmodulin-dependent protein kinase II attenuates the dependence and relapse to morphine differently in rats. Neurosci. Lett. 291, 191-195
34. Ren, X., Noda, Y., Mamiya, T., Nagai, T., and Nabeshima, T. (2004) A neuroactive steroid, dehydroepiandrosterone sulfate, prevents the development of morphine dependence and tolerance via c-fos expression linked to the extracellular signalregulated protein kinase. Behav. Brain Res. 152, 243-250
35. Kobayashi, H., Kitamura, T., Sekiguchi, M., Homma, M. K., Kabuyama, Y., Konno, S., Kikuchi, S., and Homma, Y. (2007) Involvement of EphB1 receptor/EphrinB2 ligand in neuropathic pain. Spine 32, 1592-1598
36. Song, X. J., Cao, J. L., Li, H. C., Zheng, J. H., Song, X. S., and Xiong, L. Z. (2008) Upregulation and redistribution of ephrinB and EphB receptor in dorsal root ganglion and spinal dorsal horn neurons after peripheral nerve injury and dorsal rhizotomy. Eur. J. Pain 12, 1031-1039
37. Battaglia, A. A., Sehayek, K., Grist, J., McMahon, S. B., and Gavazzi, I. (2003) EphB receptors and ephrin-B ligands regulate spinal sensory connectivity and modulate pain processing. Nat. Neurosci. 6, 339-340
38. Song, X. J., Zheng, J. H., Cao, J. L., Liu, W. T., Song, X. S., and Huang, Z. J. (2008) Ephrin-EphB receptor signaling contributes to neuropathic pain by regulating neural excitability and spinal plasticity in rats. Pain 139, 168-180
39. Cao, J. L., He, J. H., Ding, H. L., and Zeng, Y. M. (2005) Activation of the spinal ERK signaling pathway contributes naloxone-precipitated withdrawal in morphine-dependent rats. Pain 118, 336-349
40. Jhamandas, K. H., Marsala, M., Ibuki, T., and Yaksh, T. L. (1996) Spinal amino acid release and precipitated withdrawal in rats chronically infused with spinal morphine. J. Neurosci. 16, 2758-2766
41. Marshall, D. C., and Buccafusco, J. J. (1985) Spontaneous morphine withdrawal from the rat spinal cord. Experientia 41, 1151-1152
42. Rohde, D. S., and Basbaum, A. I. (1998) Activation of coeruleospinal noradrenergic inhibitory controls during withdrawal from morphine in the rat. J. Neurosci. 18, 4393-4402
43. Rohde, D. S., Detweiler, D. J., and Basbaum, A. I. (1996) Spinal cord mechanisms of opioid tolerance and dependence: Fos-like immunoreactivity increases in subpopulations of spinal cord neurons during withdrawal. Neuroscience 72, 233-242
44. Rohde, D. S., McKay, W. R., Abbadie, C., and Basbaum, A. I. (1997) Contribution of sacral spinal cord neurons to the autonomic and somatic consequences of withdrawal from morphine in the rat. Brain Res. 745, 83-95
45. Trang, T., Sutak, M., Quirion, R., and Jhamandas, K. (2003) Spinal administration of lipoxygenase inhibitors suppresses behavioural and neurochemical manifestations of naloxone-precipitated opioid withdrawal. Br. J. Pharmacol. 140, 295-304
46. Kerr, B. J., Cafferty, W. B., Gupta, Y. K., Bacon, A., Wynick, D., McMahon, S. B., and Thompson, S. W. (2000) Galanin knockout mice reveal nociceptive deficits following peripheral nerve injury. Eur. J. Neurosci. 12, 793-802
47. Bundesen, L. Q., Scheel, T. A., Bregman, B. S., and Kromer, L. F. (2003) Ephrin-B2 and EphB2 regulation of astrocyte-meningeal fibroblast interactions in response to spinal cord lesions in adult rats. J. Neurosci. 23, 7789-7800
48. Trang, T., Ma, W., Chabot, J. G., Quirion, R., and Jhamandas, K. (2006) Spinal modulation of calcitonin gene-related peptide by endocannabinoids in the development of opioid physical dependence. Pain 126, 256-271
49. Kullander, K., and Klein, R. (2002) Mechanisms and functions of Eph and ephrin signalling. Nat. Rev. Mol. Cell Biol. 3, 475-486
50. Palmer, A., and Klein, R. (2003) Multiple roles of ephrins in morphogenesis, neuronal networking, and brain function. Genes Dev. 17, 1429-1450
51. Mao, J., and Mayer, D. J. (2001) Spinal cord neuroplasticity following repeated opioid exposure and its relation to pathological pain. Ann. N. Y. Acad. Sci. 933, 175-184
52. Cull-Candy, S., Brickley, S., and Farrant, M. (2001) NMDA receptor subunits: diversity, development and disease. Curr. Opin. Neurobiol. 11, 327-335
53. Prybylowski, K., and Wenthold, R. J. (2004) N-Methyl-D-aspartate receptors: subunit assembly and trafficking to the synapse. J. Biol. Chem. 279, 9673-9676
54. Boyce, S., Wyatt, A., Webb, J. K., O'Donnell, R., Mason, G., Rigby, M., Sirinathsinghji, D., Hill, R. G., and Rupniak, N. M. (1999) Selective NMDA NR2B antagonists induce antinociception without motor dysfunction: correlation with restricted localisation of NR2B subunit in dorsal horn. Neuropharmacology 38, 611-623
55. Nagy, G. G., Watanabe, M., Fukaya, M., and Todd, A. J. (2004) Synaptic distribution of the NR1, NR2A and NR2B subunits of the N-methyl-d-aspartate receptor in the rat lumbar spinal cord revealed with an antigen-unmasking technique. Eur. J. Neurosci. 20, 3301-3312
56. Bajo, M., Crawford, E. F., Roberto, M., Madamba, S. G., and Siggins, G. R. (2006) Chronic morphine treatment alters expression of N-methyl-D-aspartate receptor subunits in the extended amygdala. J. Neurosci. Res. 83, 532-537
57. Murai, K. K., and Pasquale, E. B. (2004) Eph receptors, ephrins, and synaptic function. Neuroscientist 10, 304-314
58. Nakazawa, T., Komai, S., Tezuka, T., Hisatsune, C., Umemori, H., Semba, K., Mishina, M., Manabe, T., and Yamamoto, T. (2001) Characterization of Fyn-mediated tyrosine phosphorylation sites on GluR epsilon 2 (NR2B) subunit of the N-methyl-D-aspartate receptor. J. Biol. Chem. 276, 693-699
59. Fan, G. H., Wang, L. Z., Qiu, H. C., Ma, L., and Pei, G. (1999) Inhibition of calcium/calmodulin-dependent protein kinase II in rat hippocampus attenuates morphine tolerance and dependence. Mol. Pharmacol. 56, 39-45
60. Sheng, M., Thompson, M. A., and Greenberg, M. E. (1991) CREB: a Ca(2+)-regulated transcription factor phosphorylated by calmodulin-dependent kinases. Science 252, 1427-1430
61. Contractor, A., Rogers, C., Maron, C., Henkemeyer, M., Swanson, G. T., and Heinemann, S. F. (2002) Trans-synaptic Eph receptor-ephrin signaling in hippocampal mossy fiber LTP. Science 296, 1864-1869
62. Nateri, A. S., Raivich, G., Gebhardt, C., Da Costa, C., Naumann, H., Vreugdenhil, M., Makwana, M., Brandner, S., Adams, R. H., Jefferys, J. G., Kann, O., and Behrens, A. (2007) ERK activation causes epilepsy by stimulating NMDA receptor activity. EMBO J. 26, 4891-4901
63. Ma, W., Zheng, W. H., Powell, K., Jhamandas, K., and Quirion, R. (2001) Chronic morphine exposure increases the phosphorylation of MAP kinases and the transcription factor CREB in dorsal root ganglion neurons: an in vitro and in vivo study. Eur. J. Neurosci. 14, 1091-1104
64. Watson, A., and Latchman, D. (1995) The cyclic AMP response element in the calcitonin/calcitonin gene-related peptide gene promoter is necessary but not sufficient for its activation by nerve growth factor. J. Biol. Chem. 270, 9655-9660
65. Jassen, A. K., Yang, H., Miller, G. M., Calder, E., and Madras, B. K. (2006) Receptor regulation of gene expression of axon guidance molecules: implications for adaptation. Mol. Pharmacol. 70, 71-77